AA
51
3
COP
56
2
FMC
31
5
PCG
93
2
CVS
48
3
VFC
47
-5
AFL
46
-3
DAL
80
-4
EQR
54
-2
BBY
40
3
LUV
39
-5
EOG
58
2
MAS
51
4
INTU
51
2
MS
74
-2
SO
55
-2
HCP
58
4
QCOM
48
-7
WDC
41
-2
DNB
78
6
AA
51
3
COP
56
2
FMC
31
5
PCG
93
2
CVS
48
3
VFC
47
-5
AFL
46
-3
DAL
80
-4
EQR
54
-2
BBY
40
3
LUV
39
-5
EOG
58
2
MAS
51
4
INTU
51
2
MS
74
-2
SO
55
-2
HCP
58
4
QCOM
48
-7
WDC
41
-2
DNB
78
6
Financhill
Back

Blueprint Medicines Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
37

BPMC
Blueprint Medicines

Last Price:
97.38
Seasonality Move:
-0.18%
Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
754.03
Seasonality Move:
14.6%
Sell
37
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $94.81. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $743.35. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $94.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $743.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.39 Buy
Relative Strength Index (14 RSI): 54.43 Buy
Chaikin Money Flow: 456578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.11 - 97.25) Buy
Bollinger Bands (100): (85.77 - 106.49) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -62 Sell
Relative Strength Index (14 RSI): 13.08 Sell
Chaikin Money Flow: 151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (783.29 - 941.63) Sell
Bollinger Bands (100): (917.99 - 1161.21) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.66 Buy
20-day SMA: 92.39 Buy
50-day SMA: 90.02 Buy
200-day SMA: 95.85 Sell
8-day EMA: 94.12 Buy
20-day EMA: 93.09 Buy
50-day EMA: 92.24 Buy
200-day EMA: 91.11 Buy

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 780.04 Sell
20-day SMA: 834.53 Sell
50-day SMA: 964.64 Sell
200-day SMA: 1003.34 Sell
8-day EMA: 775.42 Sell
20-day EMA: 832.12 Sell
50-day EMA: 927.66 Sell
200-day EMA: 978.17 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.64 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):